# NEXEL Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nexel-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.nexel.co.kr
- Total disclosed funding: $8.9M
- Latest round: Series B (Sep 4, 2019)
- Investors on record: 10

## About

NEXEL Co., Ltd. is a South Korean company specializing in the creation and provision of human induced pluripotent stem cell (iPSC)-derived products for research and therapeutic use, particularly in drug discovery and regenerative medicine.Founded in 2012 in Seoul, South Korea, NEXEL Co., Ltd. develops innovative iPSC-derived cell products. The company has completed 11 deals and, as of September 6, 2023, raised a total of KRW 1 billion in venture funding, all contributing to a current company valuation of KRW 126,348.327 mn. The CEO is Anders Vikkelsø, Choong-seong Han.NEXEL specializes in developing human induced pluripotent stem cell (iPSC)-derived cell products. Their offerings include various cell types used in research and therapeutic applications in drug discovery, regenerative medicine, and disease modeling. NEXEL markets these products mainly in North America and Europe to pharmaceutical companies, academic institutions, and biotech firms, facilitating advancements in personalized medicine and new treatment solutions.In the most recent fiscal year, NEXEL reported a revenue of KRW 2,746,454.3 and an EBITDA of KRW -4,377,142 for 2024.NEXEL Co., Ltd. plans to leverage the KRW 1 billion raised in September 2023 to support the launch of new iPSC-derived products aimed at expanding their market presence. The company is targeting expansion into new geographic markets, such as Asia and North America, by 2025 to enhance their sales capabilities. This funding will facilitate product development and support strategic market entry efforts.

## Funding rounds

- Series B, Sep 4, 2019, $8.1M — UTC Investment, Medici Investment, BNK Venture Capital, Platinum Technology Investment, COMES Investment, Soo Investment Capital, Ulmus Investment
- Series A, Dec 19, 2017, $0.2M — COMES Investment
- Seed, Oct 31, 2017, $0.5M — Coolidge Corner Investment, Cosine Investment
- Seed, Mar 1, 2017 — Coolidge Corner Investment, Korea Tech Incubator for Startup

## Investors

- Coolidge Corner Investment (https://capitalatlas.ai/funds/coolidge-corner-investment) — Seed
- Korea Tech Incubator for Startup — Seed
- Cosine Investment — Seed
- COMES Investment (https://capitalatlas.ai/funds/comes-investment) — Series A, Series B
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series B
- Medici Investment (https://capitalatlas.ai/funds/medici-investment) — Series B
- BNK Venture Capital (https://capitalatlas.ai/funds/bnk-venture-capital) — Series B
- Platinum Technology Investment (https://capitalatlas.ai/funds/platinum-technology-investment) — Series B
- Soo Investment Capital (https://capitalatlas.ai/funds/soo-investment-capital) — Series B
- Ulmus Investment (https://capitalatlas.ai/funds/ulmus-investment) — Series B